Amdocs Limited (DOX) Shares Bought by Eqis Capital Management Inc.

Eqis Capital Management Inc. boosted its stake in Amdocs Limited (NASDAQ:DOX) by 10.3% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 6,364 shares of the technology company’s stock after buying an additional 593 shares during the period. Eqis Capital Management Inc.’s holdings in Amdocs Limited were worth $410,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Amdocs Limited by 1,661.3% in the first quarter. BlackRock Inc. now owns 8,715,991 shares of the technology company’s stock valued at $531,590,000 after buying an additional 8,221,139 shares during the period. FMR LLC boosted its position in shares of Amdocs Limited by 12.8% in the first quarter. FMR LLC now owns 12,620,266 shares of the technology company’s stock valued at $769,710,000 after buying an additional 1,435,539 shares during the period. Karp Capital Management Corp purchased a new position in shares of Amdocs Limited during the first quarter valued at about $51,051,000. Boston Partners boosted its position in shares of Amdocs Limited by 9.7% in the first quarter. Boston Partners now owns 7,464,464 shares of the technology company’s stock valued at $455,257,000 after buying an additional 661,397 shares during the period. Finally, Janus Capital Management LLC boosted its position in shares of Amdocs Limited by 9.7% in the first quarter. Janus Capital Management LLC now owns 6,759,428 shares of the technology company’s stock valued at $412,250,000 after buying an additional 599,865 shares during the period. 88.74% of the stock is currently owned by institutional investors.

Amdocs Limited (NASDAQ DOX) traded down 1.15% during mid-day trading on Thursday, hitting $62.53. The stock had a trading volume of 652,950 shares. The stock has a market cap of $9.09 billion, a P/E ratio of 21.78 and a beta of 0.54. The firm has a 50-day moving average of $65.26 and a 200-day moving average of $62.85. Amdocs Limited has a 52-week low of $54.91 and a 52-week high of $67.98.

Amdocs Limited (NASDAQ:DOX) last issued its earnings results on Wednesday, August 2nd. The technology company reported $1.02 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.06. The firm had revenue of $967 million during the quarter, compared to the consensus estimate of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.75%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.90 earnings per share. On average, analysts forecast that Amdocs Limited will post $3.81 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be paid a $0.22 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.88 annualized dividend and a yield of 1.41%. Amdocs Limited’s dividend payout ratio is presently 30.66%.

COPYRIGHT VIOLATION WARNING: This story was published by [[site]] and is the sole property of of [[site]]. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at [[permalink]].

Several research analysts recently issued reports on DOX shares. Zacks Investment Research cut Amdocs Limited from a “buy” rating to a “hold” rating in a research note on Tuesday, May 2nd. Jefferies Group LLC reissued a “hold” rating and issued a $59.00 price objective on shares of Amdocs Limited in a research note on Friday, June 16th. Stifel Nicolaus reaffirmed a “buy” rating and set a $68.00 target price on shares of Amdocs Limited in a research report on Wednesday, June 28th. BidaskClub cut Amdocs Limited from a “hold” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, Robert W. Baird increased their target price on Amdocs Limited from $62.00 to $66.00 and gave the company a “neutral” rating in a research report on Wednesday, May 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $67.63.

About Amdocs Limited

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.